
186PEfficacy of dose-dense (DD) adjuvant chemotherapy (CT) in hormone receptor positive/HER2-negative early breast cancer (BC) patients (pts) according to immunohistochemically (IHC) defined luminal subtypes: An exploratory analysis of the GIM2 trial
Conte, B, Bruzzone, M, Lambertini, M, Poggio, F, Blondeaux, E, De Laurentiis, M, Valle, E, Cognetti, F, Nisticò, C, De Placido, S, Merlano, M C, Gamucci, T, Montemurro, F, Ceppi, M, Del Mastro, LVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz240.012
Date:
October, 2019
Fichier:
PDF, 90 KB
2019